Thomas John Charles (CIK 2114900) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-26). Recent activity: Buy KRYS (1,000 shares), Sell KRYS (1,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Krystal Biotech, Inc. (KRYS) | EVP, General Counsel | Buy | 1,000 | $179,250 |
| 2026-06-26 | Krystal Biotech, Inc. (KRYS) | EVP, General Counsel | Sell | 1,000 | $347,270 |
Source: SEC Form 4 filings · as of 2026-06-26